Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Despina Yancopoulou

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Neuromolecular Medicine|October 7, 2003
Tau protein in familial and sporadic diseasesDespina Yancopoulou, Maria Grazia Spillantini
Expert Review of Hematology|September 13, 2014
Complement in paroxysmal nocturnal hemoglobinuria: exploiting our current knowledge to improve the treatment landscapeDimitrios C Mastellos, Daniel Ricklin, Despina Yancopoulou, et al.
The Journal of Clinical Investigation|October 7, 2021
Phase IIa clinical trial of complement C3 inhibitor AMY-101 in adults with periodontal inflammationHatice Hasturk, George Hajishengallis, , et al.
Journal of Neuropathology and Experimental Neurology|April 5, 2005
Tau and alpha-synuclein inclusions in a case of familial frontotemporal dementia and progressive aphasiaDespina Yancopoulou, John H Xuereb, R Anthony Crowther, et al.
Seminars in Hematology|July 24, 2018
Expanding Complement Therapeutics for the Treatment of Paroxysmal Nocturnal HemoglobinuriaDimitrios C Mastellos, Edimara S Reis, Despina Yancopoulou, et al.
Journal of Neuropathology and Experimental Neurology|September 25, 2003
Tau protein in frontotemporal dementia linked to chromosome 3 (FTD-3)Despina Yancopoulou, R Anthony Crowther, Lisa Chakrabarti, et al.
Immunobiology|June 30, 2016
From orphan drugs to adopted therapies: Advancing C3-targeted intervention to the clinical stageDimitrios C Mastellos, Edimara S Reis, Despina Yancopoulou, et al.
Seminars in Immunology|March 30, 2016
Complement inhibition in pre-clinical models of periodontitis and prospects for clinical applicationGeorge Hajishengallis, Evlambia Hajishengallis, Tetsuhiro Kajikawa, et al.
Clinical Immunology (Orlando, Fla.)|September 6, 2015
Applying complement therapeutics to rare diseasesEdimara S Reis, Dimitrios C Mastellos, Despina Yancopoulou, et al.
Archives of Neurology|September 15, 2005
Association between tau H2 haplotype and age at onset in frontotemporal dementiaBarbara Borroni, Despina Yancopoulou, Miho Tsutsui, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Neuromolecular Medicine|October 7, 2003
Tau protein in familial and sporadic diseasesDespina Yancopoulou, Maria Grazia Spillantini
Expert Review of Hematology|September 13, 2014
Complement in paroxysmal nocturnal hemoglobinuria: exploiting our current knowledge to improve the treatment landscapeDimitrios C Mastellos, Daniel Ricklin, Despina Yancopoulou, et al.
The Journal of Clinical Investigation|October 7, 2021
Phase IIa clinical trial of complement C3 inhibitor AMY-101 in adults with periodontal inflammationHatice Hasturk, George Hajishengallis, , et al.
Journal of Neuropathology and Experimental Neurology|April 5, 2005
Tau and alpha-synuclein inclusions in a case of familial frontotemporal dementia and progressive aphasiaDespina Yancopoulou, John H Xuereb, R Anthony Crowther, et al.
Seminars in Hematology|July 24, 2018
Expanding Complement Therapeutics for the Treatment of Paroxysmal Nocturnal HemoglobinuriaDimitrios C Mastellos, Edimara S Reis, Despina Yancopoulou, et al.
Journal of Neuropathology and Experimental Neurology|September 25, 2003
Tau protein in frontotemporal dementia linked to chromosome 3 (FTD-3)Despina Yancopoulou, R Anthony Crowther, Lisa Chakrabarti, et al.
Immunobiology|June 30, 2016
From orphan drugs to adopted therapies: Advancing C3-targeted intervention to the clinical stageDimitrios C Mastellos, Edimara S Reis, Despina Yancopoulou, et al.
Seminars in Immunology|March 30, 2016
Complement inhibition in pre-clinical models of periodontitis and prospects for clinical applicationGeorge Hajishengallis, Evlambia Hajishengallis, Tetsuhiro Kajikawa, et al.
Clinical Immunology (Orlando, Fla.)|September 6, 2015
Applying complement therapeutics to rare diseasesEdimara S Reis, Dimitrios C Mastellos, Despina Yancopoulou, et al.
Archives of Neurology|September 15, 2005
Association between tau H2 haplotype and age at onset in frontotemporal dementiaBarbara Borroni, Despina Yancopoulou, Miho Tsutsui, et al.
Pageof 3